Utility of assessing CMV specific reactivity in BAL

P. Draghi, N. Solari, D. Lilleri, V. Rognoni, P. Zelini, M. Morosini, A. M. Fietta, F. Meloni (Pavia, Italy)

Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Session: New clinical and experimental insights in lung transplantation
Session type: Thematic Poster Session
Number: 4851

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Draghi, N. Solari, D. Lilleri, V. Rognoni, P. Zelini, M. Morosini, A. M. Fietta, F. Meloni (Pavia, Italy). Utility of assessing CMV specific reactivity in BAL. Eur Respir J 2010; 36: Suppl. 54, 4851

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytomegalovirus (CMV) infection – Correlation between CMV-DNA PCR in bronchoalveolar lavage (BAL), CMV pp65 antigen load in PBMCs and clinical symptoms in lung transplant recipients
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Identification of bacterial pulmonary infection by a PCR based rapid molecular diagnostic assay in bronchoalveolar lavage
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Evaluation of ADA activity in BAL fluid in patients with smear negative pulmonary tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Comparison among BAL biomarkers in ILD discrimination and course prediction
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001

Comparison of the diagnostic value of immunological test, applied to two types of biological fluids - venous blood and bronchoalveolar lavage in children with tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Characterization of the lymphocyte phenotype in bronchoalveolar lavage as a prognostic marker in pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019


Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
Source: Eur Respir J, 56 (5) 2003116; 10.1183/13993003.03116-2020
Year: 2020



Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
Source: Eur Respir J, 56 (5) 2003383; 10.1183/13993003.03383-2020
Year: 2020



Comparative analysis of surface antigen expression and DNA content in circulating, tissue and bronchoalveolar lavage lymphocytes in patients with COPD after radiation exposure
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients
Source: Eur Respir J 2003; 22: Suppl. 45, 201s
Year: 2003

Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

Clinical significance of Mycobacterium tuberculosis (MBT) DNA detection in bronchoalveolar lavage and bronchial biopsy in HIV-infected patients
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005

Rapid diagnosis of smear negative pulmonary tuberculosis by enumeration of MTB-specific mononuclear cells from the bronchoalveolar lavage (BAL)
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006


Diagnostic value of bronchoalveolar lavage and lymphocyte transformation test in drug-induced lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Improving automated cell recognition of sputum and BAL cells for Chipcytometry analysis
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Evaluation of bacterial colonisation by quantitative culturing method in sputum and bronchoalveolar lavage fluid of patients with bronchiectasis in the stable period
Source: Annual Congress 2004 - Bronchiectasis
Year: 2004


Impact of processing technique on bronchoalveolar lavage cellular analysis
Source: Eur Respir J, 51 (3) 1701769; 10.1183/13993003.01769-2017
Year: 2018



Diagnostic value of bronchoalveolar lavage (BAL) in sputum smear negative pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Correlation between T-cell activation markers on lymphocytes from peripheral blood and bronchoalveolar lavage fluid in sarcoidosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003